Fuller & Thaler Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67.6M | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $27K | Hold |
|
|||||
|
2021
Q3 | $30K | Hold |
|
|||||
|
2021
Q2 | $27K | Sell |
|
|||||
|
2021
Q1 | $44K | Hold |
|
|||||
|
2020
Q4 | $38K | Hold |
|
|||||
|
2020
Q3 | $34K | Hold |
|
|||||
|
2020
Q2 | $27K | Hold |
|
|||||
|
2020
Q1 | $19K | Sell |
|
|||||
|
2019
Q4 | $24K | Hold |
|
|||||
|
2019
Q3 | $21K | Hold |
|
|||||
|
2019
Q2 | $22K | Hold |
|
|||||
|
2019
Q1 | $23K | Hold |
|
|||||
|
2018
Q4 | $18K | Hold |
|
|||||
|
2018
Q3 | $21K | Hold |
|
|||||
|
2018
Q2 | $17K | Hold |
|
|||||
|
2018
Q1 | $17K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $40K | Hold |
|
|||||
|
2015
Q3 | $32K | Buy |
|